MedPath

APO-NALTREXONE

APO-NALTREXONE

Approved
DIN Number

02444275

Drug Class

Human

Market Date

Nov 10, 2015

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02444275
AIG Number0118591001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07BB04 NALTREXONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:10.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

NALTREXONE HYDROCHLORIDEActive
Strength: 50 MG
Monograph: NALTREXONE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.